Post by PANTERA

Yesterday PANTERA celebrated the ground breaking of their Actinium Production Center, (APC) a state-of-the-art facility that will become a cornerstone in the global supply of Actinium-225 (Ac-225), a promising isotope for targeted alpha therapy in cancer treatment.🩵 Construction of the APC will be led by the Wisico consortium, comprising Willemen Bouw ,Cordeel Belgium, SPIE, and Imtech, based on designs developed by TRACTEBEL and MODULO architects. The building is scheduled to become operational in 2028, with the first commercial supply of Ac-225 expected in 2029. Once fully ramped up, the APC will be capable of producing hundreds of curies of Ac-225 annually, securing reliable access to this vital isotope for pharmaceutical companies and patients worldwide.🌍 “This groundbreaking represents more than just the start of construction—it symbolizes PanTera’s commitment to enabling the future of cancer therapy. With the APC, we will unlock large-scale and sustainable production of Ac-225, providing the reliability that the medical community urgently needs,” said Sven Van den Berghe, CEO. Read the full press release here ⬇️ https://lnkd.in/e5yWZmpX